Table 1.
Receptor/binding site | Receptor source | [Radioligand] | Non-specific binding in the presence of | Incubation time and temperature | Reference |
---|---|---|---|---|---|
Dopamine D1 | Rat striatum | 0.35 nM, [3H]SCH23390 | 3 μM, cis-flupenthixol | 20 min, 37°C | Billard et al. (1984) |
Dopamine D2 | Rat striatum | 0.15 nM, [3H]spiperone | 3 μM, (+)butaclamol | 15 min, 37°C | Fields et al. (1977) |
Dopamine D3 | Rat olfactory tubercles | 0.70 nM, [3H]7-OHDPAT | 1 μM, dopamine | 60 min, 25°C | Lévesque et al. (1992) |
Dopamine uptake site | Rat striatum | 2.0 nM, [3H]WIN35,428 | 100 μM, cocaine | 30 min, 4°C | Valchar and Hanbauer (1993) |
Serotonin 5-HT1 | Rat cortex | 1.8 nM, [3H]-5HT | 5 μM, 5-HT | 20 min, 37°C | Bennet and Snyder (1976) |
Serotonin 5-HT2 | Rat prefrontal cortex | 0.6 nM, [3H]ketanserin | 3.6 μM, metergoline | 20 min, 37°C | Leysen et al. (1981) |
Serotonin 5-HT3 | Rat entorhinal cortex | 0.2 nM, [3H]GR65630 | 72 μM, quipazine | 30 min, 37°C | Kilpatrick et al. (1987) |
Serotonin uptake site | Rat forebrain | 0.04 nM, [3H]paroxetine | 100 μM, 5-HT | 60 min, 22°C | Marcusson et al. (1988) |
Benzodiazepines | Rat forebrain | 1 nM, [3H]RO15-1788 | 10 μM, diazepam | 90 min, melting ice | Chiu and Rosemberg (1983) |
GABAA | Rat cortex and cerebellum | 2.20 nM, [3H]muscimol | 20 μM, GABA | 30 min, 4°C | Yoneda and Kuriyama (1980) |
GABAB | Rat cortex | 10 nM, [3H]GABA | 100 μM, (−)baclofen | 10 min, 25°C | Enna and Snyder (1977), Herschel and Baldessarini (1979) |
Chlorine channel | Rat whole brain | 0.11 nM, [35S]TBPS | 100 μM, picrotoxinin | 120 min, 25°C | Corda et al. (1993) |
AMPA | Rat cerebral cortex | 8 nM, [3H]AMPA | 1 mM, l-glutamate | 60 min, 4°C | Murphy et al. (1987) |
NMDA | Rat cerebral cortex | 5 nM, [3H]CGP 39653 | 100 μM, l-glutamate | 60 min, 4°C | Sills et al. (1991) |
Kainate | Rat cerebral cortex | 5 nM, [3H]kainic acid | 1 mM, l-glutamate | 60 min, 4°C | Monaghan and Cotman (1982) |
GABA, γ-aminobutyric acid; TBPS, t-butylbicyclophosphorothionate; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; NMDA, N-methyl-d-aspartate.